Paré L - Search Results

1

Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer.

Marín-Aguilera M, Jares P, Sanfeliu E, Villacampa G, Hernández-Lllán E, Martínez-Puchol AI, Shankar S, González-Farré B, Waks AG, Brasó-Maristany F, Pardo F, Manning DK, Abery JA, Curaba J, Moon L, Gordon O, Galván P, Wachirakantapong P, Castillo O, Nee CM, Blasco P, Senevirathne TH, Sirenko V, Martínez-Sáez O, Aguirre A, Krop IE, Li Z, Spellman P, Metzger Filho O, Polyak K, Michaels P, Puig-Butillé JA, Vivancos A, Matito J, Buckingham W, Perou CM, Villagrasa-González P, Prat A, Parker JS, Paré L. Marín-Aguilera M, et al. Among authors: pare l. ESMO Open. 2024 Mar;9(3):102903. doi: 10.1016/j.esmoop.2024.102903. Epub 2024 Mar 6. ESMO Open. 2024. PMID: 38452436 Free PMC article.

2

Gunshot wounds: evaluating the adequacy of documentation at a Level I trauma center.

Ross RT, Hammen PF, Frantz EI, Paré LE, Boyd CR. Ross RT, et al. Among authors: pare le. J Trauma. 1998 Jul;45(1):151-2. doi: 10.1097/00005373-199807000-00031. J Trauma. 1998. PMID: 9680029 No abstract available.

3

Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy in females.

Paré L, Salazar J, del Rio E, Baiget M, Altés A, Marcuello E, Paez D, Barnadas A. Paré L, et al. J Clin Oncol. 2008 Jul 10;26(20):3468; author reply 3468-9. doi: 10.1200/JCO.2008.17.6479. J Clin Oncol. 2008. PMID: 18612168 No abstract available.

4

Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5-FU-based chemotherapy.

Paré L, Paez D, Salazar J, Del Rio E, Tizzano E, Marcuello E, Baiget M. Paré L, et al. Br J Clin Pharmacol. 2010 Aug;70(2):268-72. doi: 10.1111/j.1365-2125.2010.03683.x. Br J Clin Pharmacol. 2010. PMID: 20653680 Free PMC article.

5

Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration.

Fernandez-Rozadilla C, Cazier JB, Moreno V, Crous-Bou M, Guinó E, Durán G, Lamas MJ, López R, Candamio S, Gallardo E, Paré L, Baiget M, Páez D, López-Fernández LA, Cortejoso L, García MI, Bujanda L, González D, Gonzalo V, Rodrigo L, Reñé JM, Jover R, Brea-Fernández A, Andreu M, Bessa X, Llor X, Xicola R, Palles C, Tomlinson I, Castellví-Bel S, Castells A, Ruiz-Ponte C, Carracedo A; EPICOLON Consortium. Fernandez-Rozadilla C, et al. Among authors: pare l. Pharmacogenomics J. 2013 Jun;13(3):209-17. doi: 10.1038/tpj.2012.2. Epub 2012 Feb 7. Pharmacogenomics J. 2013. PMID: 22310351

6

Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti-EGFR-based therapy?

Paez D, Paré L, Espinosa I, Salazar J, del Rio E, Barnadas A, Marcuello E, Baiget M. Paez D, et al. Among authors: pare l. Cancer Sci. 2010 Sep;101(9):2048-53. doi: 10.1111/j.1349-7006.2010.01621.x. Cancer Sci. 2010. PMID: 20550522 Free article.

7

Pharmacogenetic analysis in the treatment of Hodgkin lymphoma.

Altés A, Paré L, Esquirol A, Xicoy B, Rámila E, Vicente L, López R, Orriols J, Vall-llovera F, Sánchez-González B, del Río E, Sureda A, Páez D, Baiget M. Altés A, et al. Among authors: pare l. Leuk Lymphoma. 2013 Aug;54(8):1706-12. doi: 10.3109/10428194.2012.752080. Epub 2013 Feb 1. Leuk Lymphoma. 2013. PMID: 23323945

8

A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer.

Marcuello E, Páez D, Paré L, Salazar J, Sebio A, del Rio E, Baiget M. Marcuello E, et al. Among authors: pare l. Br J Cancer. 2011 Jun 28;105(1):53-7. doi: 10.1038/bjc.2011.206. Epub 2011 Jun 7. Br J Cancer. 2011. PMID: 21654688 Free PMC article.

9

Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy.

Paré L, Altés A, Ramón y Cajal T, Del Rio E, Alonso C, Sedano L, Barnadas A, Baiget M. Paré L, et al. Anticancer Drugs. 2007 Aug;18(7):821-5. doi: 10.1097/CAD.0b013e3280b10d23. Anticancer Drugs. 2007. PMID: 17581305

10

Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer.

Gendoo DM, Ratanasirigulchai N, Schröder MS, Paré L, Parker JS, Prat A, Haibe-Kains B. Gendoo DM, et al. Among authors: pare l. Bioinformatics. 2016 Apr 1;32(7):1097-9. doi: 10.1093/bioinformatics/btv693. Epub 2015 Nov 24. Bioinformatics. 2016. PMID: 26607490 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page